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Summary
Ageing is a process characterised by progressive loss of
function in multiple different organ systems, such as
the nervous, endocrine and immune systems. Current
data showing that ageing processes may be associated
with alterations in the immune system suggest that
some of the genetic determinants of senescence might
be polymorphic genes that regulate immune responses.
The ‘Immunogenetics of Aging’ programme was a
component introduced in the 14th International HLA
and Immunogenetics Workshop (IHIWS) and devel-
oped further within the 15th and 16th. The aim of this
component was to determine the contribution of
immune genes to successful ageing and an increased
capacity to reach the extreme limits of lifespan. Within
the 16th IHIWS, new populations were included, and
the number of samples analysed was increased. Analy-
sis was focused on innate immunity genes (KIR and
MBL2) and their correlation with CMV serostatus.
Collaborative studies suggested that both activating
and inhibitory KIR and functionally relevant MBL2
haplotypes are important factors for control of CMV
infection in the elderly and therefore for chronic
low-grade inflammation. Results showed that these
genes might be predictive biomarkers in ageing and
longevity. Prevalence of MBL2 haplotypes determining
absence of the protein (LYPB, LYQC and HYPD) was
observed in elderly people with a higher CMV anti-
body titre. The high CMV titre was also associated
with a decreased frequency of the activatory KIR2DS5
and A1B10 haplotypes in elderly. Due to the role of
KIR and low or deficient MBL haplotypes in viral
infections, these genetic markers could be considered
as indicators of a need for CMV prophylaxis at youn-
ger age and therefore increased probability of longer
lifespan.
Introduction
Ageing is a process characterised by progressive loss of
function in multiple different organ systems, such as
the nervous, endocrine and immune systems. The
changes in the immune system are impaired generation
of lymphoid progenitors in the bone marrow, thymic
involution, loss of capacity for clonal expansion,
shrinkage of the T-cell repertoire, prevalence of highly
differentiated effector T cells and reduction of na€ıve T
cells, cytokine misbalance, impaired humoral immu-
nity, impaired function of NK cells and other innate
immune cells involved in primary immune responses.
The clinical consequences of ageing are greater suscep-
tibility to infections, higher severity of the infections
leading to higher mortality, partial loss of vaccine
efficiency, higher autoreactivity and tumorogenesis
(Fulop, 2011). From a socio-economic standpoint, the
ageing population is becoming an important issue in
the Western world. It is expected that in the next two
decades people aged 65 and older will comprise at
least 20% of the population (Gaskell et al., 2008).
This rapid skewing in the age structure of western
populations confers significant stress to healthcare sys-
tems as ageing is associated with increased prevalence
of medical conditions requiring chronic management
and leading to functional dependence. As all these
appear to be inevitable consequences of ageing, it is of
great importance to understand factors that affect
human longevity and ways to improve quality of life.
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A strong genetic component of longevity has become
apparent from studies with a variety of organisms.
Twin studies in humans revealed the magnitude of the
genetic influence on lifespan, while centenarian and
family studies suggest enrichment of longevity-promot-
ing genes. Such studies showed that somewhere
between 15% and 30% of lifespan is controlled by
our genes (Herskind et al., 1996; Mitchell et al.,
2001). Studies on centenarians, on the other hand,
suggest that they owe their good fortune to their
inheritance of a small number of powerfully acting
longevity genes. Several groups of genes have been
investigated for their possible association with human
longevity. These include inflammatory and immune-
related factors, stress response elements, mediators of
glucose and lipid metabolism, components of DNA
repair and cellular proliferation and mitochondrial
DNA haplogroups. Currently, there is a consensus that
many aspects of senescence are characterised by
increased inflammatory status, leading to extended tis-
sue damage. Chronic inflammation has been associated
with several age-related diseases, including atheroscle-
rosis, obesity, type 2 diabetes and cancer (Franceschi
et al., 2000; Cavallone et al., 2003; Chamorro, 2004;
Dandona et al., 2004). The extent to which age-asso-
ciated changes depend on the genetic background
needs to be established. Current data showing that
ageing processes may be associated with alterations in
the immune system suggest that some of the genetic
determinants of senescence might be polymorphic
genes that regulate immune responses. These genes
include those of the most highly polymorphic system
known, the human leucocyte antigen (HLA) genes, as
well as genes encoding ‘atypical’ HLA-like molecules
(CD1, etc.); killer-cell immunoglobulin-like receptor
genes (KIR); leucocyte Fc receptor genes; cytokine and
cytokine receptor genes; Toll-like receptor gene family;
TNF-receptor associated factors; and mannose-binding
lectin 2 (MBL2). Although there are some reports on
the possible association of these genes with human
longevity and age-related diseases, their impact still
remains to be established through collaborative studies
on different populations.
The ‘Immunogenetics of Aging’ programme was a
component introduced in the 14th International
HLA and Immunogenetics Workshop (IHIWS) and
developed further within the 15th and 16th. The
aim of this component was to determine the contri-
bution of immune genes to successful ageing and an
increased capacity to reach the extreme limits of life-
span. The following sample groups were collected:
families with long-lived members (octogenarians and
nonagenarians) and unrelated elderly individuals
compared with ethnically matched young controls.
As part of 14th and 15th IHIWS, the effect of
classical HLA class I and class II loci and cytokine
polymorphisms in regulatory and/or coding regions,
with a possible impact on the level of gene expres-
sion of pro- and anti-inflammatory cytokines, was
analysed (Naumova et al., 2007, 2011). Some preli-
minary data on the impact of innate immunity genes
such as KIR and MBL2 in the Bulgarian population
were generated.
Materials and methods
During the 16th IHIWS, the number of samples col-
lected was increased, and new populations were
included. Two sample groups were included in the
component ‘Immunogenetics of Aging’: unrelated
healthy elderly individuals and ethnically matched
young controls. Elderly individuals were characterised
according to the SENIEUR protocol (Ligthart et al.,
1984). The unrelated young controls were character-
ised according to the JUNIEUR protocol (Ligthart
et al., 1984). Data on eight populations (Bulgarian,
Romanian, Polish, Turkish, Italian, Irish, Danish and
Indian) are included with a total number of 973
elderly, 778 young controls and 12 families with
long-lived members, including 17 unrelated elderly
(65–90 years) and 23 family members (18–57 years)
analysed. During the 16th IHIWS, two new popula-
tions, Danish and Indians, were included and addi-
tional 371 healthy randomly selected elderly
individuals (aged 65–99) and 385 young controls were
included.
Innate immunity genes KIR and MBL2 and their
possible correlation with CMV status were analysed
within the 16th IHIWS. KIR genotyping was per-
formed by PCR sequence-specific oligonucleotide
(PCR-SSO) and PCR sequence-specific primers
(PCR-SSP) methods. For the analysis of MBL2 haplo-
types, including six SNPs: rs 1100312 [-619 C/G
(L/H)], rs 7096206 [-290 G/C (Y/X)], rs 7095891
[-66 C/T (P/Q)], rs 5030737 [cdn 52 C/T Arg>Cys (A/
D)], rs 1800450 [cdn 54 G/A Gly>Asp (A/B)],
rs 1800451 [cdn 57 A/G Gly>Glu (A/C)] associated
with the protein level, a Luminex-based method was
applied. CMV status was assessed by ELISA, and
CMV viral load was estimated by RT-PCR.
Allele frequencies were estimated by maximum-like-
lihood analysis using the Arlequin program v1.1
(Ivanova et al., 2008). Standard deviations were calcu-
lated from 100 bootstrap iterations. Hardy–Weinberg
equilibrium was tested by a hidden Markov chain with
100 000 steps, implemented in the Arlequin program.
Arlequin software was also used to estimate maxi-
mum-likelihood three-locus haplotype frequencies
from genotypic data through an expectation-maximi-
sation (EM) algorithm (Slatkin & Excoffier, 1996).
Haplotypes were confirmed by inheritance in families.
Comparisons across different age groups and groups
with different CMV status were assessed by the chi-
squared test or Fischer exact test when appropriate.
A P-value lower than 0.05 was considered to indicate
a significant difference between groups. Bonferroni
correction for multiple comparisons was applied where
appropriate.
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Results and discussion
HLA
Results from 14th and 15th IHIWS showed positive
association of human longevity with HLA-DRB1*11
and HLA-DRB1*16 haplotypes that are protective for
autoimmune diseases. During the 16th IHIWS, these
data were further extended by analysis of Asian Indian
population. Results in this population showed statisti-
cally significant negative association of longevity with
B*15 (elderly AF-0.097; controls AF-0.307;
P < 0.001), C*07 (elderly AF-0.250; controls AF-
0.548; P < 0.0001) and C*15 (elderly AF-0.132; con-
trols AF-0.575; P < 0.0001) specificities.
MBL2 haplotypes
It is well established that the serum levels of MBL –
the mediator of complement activation – are highly
variable and are genetically determined. Three inde-
pendent single nucleotide polymorphisms (SNPs): cdn
52 (C/T; Arg/Cys, allele D); cdn 54 (G/A; Gly/Asp,
allele B); cdn 57 (G/A; Gly/Glu, allele C) disrupt the
collagenous structure of the protein and dramatically
reduce serum MBL concentrations (Madsen et al.,
1994). Any of these mutations (B, C or D) is referred
to as O, whereas the wild type is referred to as A. In
addition to exon 1 SNPs, three regulatory variants in
the promoter and in the 5 = UTR regions at positions:
-619 (C/G, allele L/H), -290 (G/C; allele Y/X) and -66
(C/T; allele P/Q) also influence final serum MBL con-
centration. Combinations of these six SNPs result in
widespread haplotypes, determining different serum
MBL levels (Madsen et al., 1995, 1998): deficiency
(haplotypes LYPB, LYQC, HYPD); low level (haplo-
type LXPA); intermediate level (haplotype LYPA); and
high level (haplotypes HYPA and LYQA). MBL allele
and haplotype distribution is quite diverse in different
populations, and MBL deficiency is one of the most
common immune deficiencies. Studies in different eth-
nic groups (Ivanova et al., 2008) showed a high,
almost similar (25–28%) proportion of haplotypes
associated with MBL deficiency. Different hypotheses
were proposed to explain the unusually high frequency
of MBL2-deficient genetic variants worldwide, includ-
ing a protective effect of the low serum MBL against
infections especially those with intracellular bacteria
or parasites (Hoal-Van Helden et al., 1999) or alterna-
tively, reduction of deleterious effects of complement-
mediated inflammation. Although many individuals
with low MBL levels are asymptomatic, clinical symp-
toms are apparent in the presence of additional
immune defects. Genetically determined MBL defi-
ciency has been associated with an increased suscepti-
bility to many infections in cases of compromised
adaptive immunity, for example, in early childhood
(Cedzynski et al., 2004; Wiertsema et al., 2006), in
cases of inherited and acquired immune deficiencies,
after chemotherapy (Mlle et al., 2006) or after HSCT
(Granell et al., 2006). Furthermore, MBL insufficiency
is thought to influence some autoimmune diseases such
as systemic lupus erythematosis (SLE; Takahashi et al.,
2005) and rheumatoid arthritis (Graudal & Madsen,
1998). Considering these, we hypothesised that MBL2
gene polymorphism might be a possible factor contrib-
uting to human longevity. To test this hypothesis in
cross-sectional and longitudinal studies, we have tested
six MBL2 SNPs in the following populations Bulgari-
ans, Romanians and Danish. Results showed a ten-
dency towards a decreased frequency of the LYPA
haplotype associated with intermediate serum levels
and an increased frequency of LYPB determining MBL
deficiency in elderly compared with young controls,
although the difference did not achieve statistical
significance (Table 1). Additionally, the two haplo-
types LYPD and HXPA, the functional relevance of
which remains to be established, were observed both
in elderly and young controls. As ageing is associated
with chronic low-grade inflammatory activity possibly
related to CMV infection, we further correlated MBL2
polymorphism and CMV antibody level. Data from
the 16th IHWS on the increased number of subjects
confirmed our previous results (Naumova et al., 2011)
showing prevalence of MBL2 haplotypes determining
Table 1. The most frequent mannose-binding lectin 2 (MBL2) haplotypes in elderly compared to young controls – Bulgarian, Romanian, Danish
population
Haplotype HF – Bulgarians HF – Romanians
HF – Danish
HF – combined
-619 -290 -66 cdn 52 cdn 54 cdn 57 MBL2 level Elderly Controls Elderly Controls Elderly Elderly Controls
G G C C G G High HYPA 0.289 0.276 0.283 0.150 0.024 0.226 0.213
C G T C G G High LYQA 0.108 0.173 0.233 0.081 0.102 0.151 0.127
C G C C G G Interm LYPA 0.024 0.000 0.175 0.314 0.025 0.069 0.214
C C C C G G Low LXPA 0.217 0.265 0.091 0.260 0.359 0.203 0.262
C G C C A G Absence LYPB 0.205 0.133 0.075 0.051 0.119 0.161 0.092
G G C T G G Absence HYPD 0.157 0.192 0.083 0.000 0.056 0.116 0.102
C G T C G A Absence LYQC 0.000 0.029 0.000 0.000 0.000 0.000 0.020
C G C T G G ? LYPD 0.000 0.010 0.017 0.017 0.038 0.021 0.013
G C C C G G ? HXPA 0.060 0.010 0.000 0.067 0.092 0.062 0.047
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absence of the protein (LYPB, LYQC, and HYPD) in
elderly people with a CMV antibody titre of
>20 IU lL1 (haplotype frequency 0.37) compared
with those with a titre of <20 IU mL1 (haplotype
frequency 0.26).
KIR polymorphism
Within the 15th and 16th IHWS, we also focused on
KIR polymorphism as another innate immunity gene
system possibly involved in longevity. In addition to
the data from the 15th IHWS showing an possibly
increased frequency of 2DS3 (elderly GF-40.9%, con-
trols GF-25.0%, P < 0.05, Pc = ns) and KIR2DL5
(elderly GF-59.1%, controls GF-45.0%) in the aged
compared with the young controls in the Irish popula-
tion, extended data in Bulgarians showed of a higher
frequency of KIR2DL2 and lower KIR2DL3 and 2DS1
in elderly people (Fig. 1). Additionally, analysis of
haplotypes determined according to the model of Mid-
dleton et al. (2005) showed increased frequencies of
A1B1, A1B3 and A1B4 and a decreased frequency of
A1B10 the elderly group (Table 2).
Several studies reported an association between
KIR genes and the outcome of some viral infections
(Martin & Carrington, 2005; Kulkarni et al., 2008;
Romero et al., 2008; Zaia et al., 2009). Data on the
role of KIR in the control of CMV infection are lim-
ited and include studies mainly in transplant recipi-
ents (Zaia et al., 2009). Studies on the increased
number of subjects in the Bulgarian population
within the 16th IHIWS confirmed previous data
(Naumova et al., 2011) that a higher CMV-specific
IgG antibody level in elderly individuals was associ-
ated with a decreased frequency of the activatory
KIR2DS5 and A1B10 haplotypes. Interestingly, the
presence of the A1B10 profile in combination with
HLA-DR11 and DR16 (alleles contained within lon-
gevity-associated HLA haplotypes) was noted in indi-
viduals with low-grade CMV seropositivity
(<20 IU mL1). It is very likely that epistatic interac-
tions between certain HLA and KIR haplotypes may
contribute to initiating dynamic immune responses
facilitating successful ageing, while some haplotype
combinations could be related to suboptimal immune
response and to reduced lifespan.
At the end of the 16th IHIWS, a consensus was
reached on recommendations for future progress. It
was concluded that additional samples and data from
different populations should be collected. It is also
critical to incorporate additional, possibly functionally
relevant polymorphisms in other immune genes: for
example, KIR/Ligand combinations, TLR4, CD14,
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Figure 1. Killer-cell immunoglobulin-like receptor (KIR) gene frequencies in elderly compared to young individuals from the Bulgarian population.
Table 2. Frequencies of killer-cell immunoglobulin-like receptor
haplotypes in Bulgarians
Haplotype
Haplotype frequencies (%)
Elderly individuals Young controls
AxAx 4.5 0
A1B1 13.6 0
A1B2 0 5.9
A1B3 13.6 5.9
A1B4 13.6 5.9
A1B6 4.5 5.9
A1B5 9.1 5.9
A1B10a 9.1 17.6
A3B2 4.5 0
A3B4 4.5 0
A3B10 0 5.9
A4B5 0 5.9
A1Bx 9.1 29.4
AxBx 13.6 0
A3Bx 0 5.9
AxB4 0 5.9
aIn combination with DRB1*11 and DRB1*16 increased in individuals
with CMV <20 IU mL1.
Values in bold show a trend with non signiﬁcant p value.
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CCR5 and MMP3. Another possible study would be
to include genes associated with the constant decrease
in hematopoietic function with age: ageing of the stem
cell niche rendering less efficient HSC self-renewal,
decline in the relative size of the HSC population, less
efficient mobilisation properties, skewed differentiation
profiles with age and also to include genes related to a
frequent cause of bone marrow failure associated with
a lack of genome stability which leads to myelodys-
plastic syndrome and overt leukaemias.
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